FAIR VALUE MEASUREMENT - Narrative (Details) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions		3 Months Ended		12 Months Ended
	Mar. 02, 2021 USD ($)	Mar. 31, 2026 USD ($) shares	Mar. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2021 USD ($)	Mar. 31, 2026 $ / shares	Mar. 30, 2026 $ / shares	Dec. 31, 2025 USD ($)	Apr. 30, 2025 shares	Apr. 06, 2023 $ / shares shares	Nov. 14, 2022 USD ($)	Nov. 14, 2022 CAD ($) $ / shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss on change in fair value of financial instruments		$ 8,868	$ 126
Investment in unconsolidated entity		8,600						$ 8,800
Debt conversion option		13,779						5,187
Purchase option	$ 8				$ 8
Purchase option, term					5 years
Purchase option, extension term					2 years
Percentage of outstanding shares					10.00%
Warrants expiration period					60 days
Loss on change in fair value of purchase option			52
Debt Conversion Option
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized loss on hedging instruments		8,662	(78)
Debt conversion option		13,779						5,187
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in unconsolidated entity		8,600						8,800
Debt conversion option		0						0
Debt Interest Rate Conversion Feature
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized loss on hedging instruments		6	53
Debt Interest Rate Conversion Feature | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset		202						211
Business Combination, Purchase Options | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business combination, purchase option								0
BAT Group
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible, ownership percentage of shares (as a percent)											19.90%	19.90%
Conversion price (in cad per share) | $ / shares												$ 2.00
BAT Group | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Accrued interest rate (as a percent)											5.00%	5.00%
BAT Group | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Accrued interest rate (as a percent)											1.50%	1.50%
BAT Group | Convertible Notes Payable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount		$ 63,839						63,944			$ 56,800	$ 75.3
Convertible, ownership percentage of shares (as a percent)		19.90%
Conversion price (in cad per share) | $ / shares						$ 2.00	$ 0.94
DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method ownership (as a percent)		50.00%
British American Tobacco | DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred units ownership (as a percent)		100.00%
AJNA Biosciences | DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method ownership (as a percent)		50.00%
DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants outstanding (in shares) | shares		4,000,000
Stock split, conversion ratio		0.1
Loss on change in fair value of financial instruments		$ 200	$ 100
Investment in unconsolidated entity		$ 8,600						$ 8,800
DeFloria, LLC | Common Class A
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of warrant or right, number of securities called by warrants or rights (in shares) | shares									0	865,052
Warrants exercise price (in cad or usd per share) | $ / shares										$ 2.89
DeFloria, LLC | British American Tobacco
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred units (in shares) | shares		2,000,000
Capital contributed		$ 10,000
Payment for convertible debt				$ 5,000
DeFloria, LLC | AJNA Biosciences
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payment for convertible debt				$ 2,000
Warrants outstanding (in shares) | shares		4,000,000